Lord's Mark Industries Receives License for Gut Microbiome Analytics Platform
Lord's Mark Industries Limited has received a manufacturing licence from Maharashtra State Licensing Authority for its Biomescan Analytics Platform, an In Vitro Diagnostic Software focused on gut microbiome analysis. Positioned as a wellness and health-information tool, Biomescan offers personalized insights into microbial diversity, metabolic functions, and disease susceptibility linked to lifestyle disorders. The gut health market in India is projected to grow significantly by 2034. The company plans to explore fertility-related applications, though clinical validation for this remains unconfirmed.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 39/100.
Outlets measured: hindustantimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 12 Aug, 02:55 pm. Other outlets followed.